- To appreciate ESC and NICE guidelines for the investigation of patients presenting with stable chest pain
- To compare the strengths and weaknesses of non-invasive imaging tests for the investigation of patients presenting with stable chest pain
- To select appropriate stress for coronary functional imaging according to patient characteristics.
- To review aspects of the cost-effectiveness of non-invasive tests of coronary function
- When evaluating a patient with suspected SCAD it is essential to calculate the pre-test probability to select the appropriate test.
- Regadenoson is currently the stress test of choice in patients with suspected SCAD, with severe chronic obstructive pulmonary disease and who cannot perform a good exercise test.
- A stress test performed with Regadenoson has a diagnostic and prognostic yield comparable to other vasodilators or an exercise test.
- Regadenoson is by far the most practical pharmacological stress protocol (independent of the weight of the patient, short infusion time, few side effects, etc.)
- Indications for Regadenoson in daily practice
- Correct use of Regadenoson
- Procedure for possible complications
- For diagnostic purpose of CAD, maximal stress is required
- Whenever 85% maximal predicted HR is not achievable, the combination of exercise with a coronary vasodilator agent is advised
- Regadenoson offers the possibility to decide upon the opportunity to administrate the vasodilator agent according to the patients’ actual exercise abilities with only a 30 sec prolongation of the duration of exercise